Phase III PlanB Final Analysis: Adjuvant TC vs EC & #8594;T in Pts With High-Risk HER2-Negative Early Breast Cancer

Slideset - TC noninferior to EC→T in patients with high-risk HER2-negative early BC with comparable 5-year DFS (90%), OS (95%), and reduced toxicity.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research